ENANTA PHARMACEUTICALS INC
ENTA·29251M106·US·Common Stock·Healthcare - Biotechnology-13D/G
ENTA (ENANTA PHARMACEUTICALS INC) is held by 75 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($47.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($35.3M), VANGUARD CAPITAL MANAGEMENT LLC ($17.7M). Net institutional sentiment: Mixed.
75
Holders
(5 Elite)
$213.4M
Total Value
58% (72)
Consensus
42 buying - 30 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 10, 2026 · Activists Aug 14, 2026 · Congress none
ActivistDTDeep Track Capital, LP5.0%Aug 14, 2026
InsiderRTRottinghaus Scott T.Tax 1K shAug 8, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 81
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer